These innovative medications , Tirzepatide , represent a remarkable advancement in treating metabolic dysfunction and potentially associated disorders. They are categorized as GLP-1 hormone activators , meaning these substances to replicate the endogenous GLP-1 substance , enhancing metabolic pro